Western blot analysis of lysates from HUVEC, HepG and Jurkat cells using Anti-CDK2 Antibody. The right hand lane represents a negative control, where the antibody is blocked by the immunising peptide.
Immunofluorescence analysis of HeLa cells using Anti-CDK2 Antibody. The right hand panel represents a negative control, where the antibody was pre-incubated with the immunising peptide.
Western blot analysis of various cells using Anti-CDK2 Antibody at 1:1,000 (4°C overnight). Goat Anti-Rabbit IgG (IRDye 800) was used as a secondary at 1:5,000 (25°C, 1 hour).
Immunohistochemical analysis of paraffin-embedded human uterus tissue using Anti-CDK2 Antibody at 1:200 (4°C overnight). Negative control was secondary antibody only.
Immunohistochemical analysis of paraffin-embedded human uterus cancer tissue using Anti-CDK2 Antibody at 1:200 (4°C overnight). Negative control was secondary antibody only.
Immunofluorescence analysis of human stomach tissue using Anti-CDK2 Antibody (red) at 1:200 (4°C overnight). Cy3 labelled secondary antibody was used at 1:300 (RT 50min). Panel A: Target. Panel B: DAPI. Panel C: Merge.
Immunofluorescence analysis of human liver tissue using Anti-CDK2 Antibody (red) at 1:200 (4°C overnight). Cy3 labelled secondary antibody was used at 1:300 (RT 50min). Panel A: Target. Panel B: DAPI. Panel C: Merge.
![SDS-PAGE - Anti-CDK2 Antibody [AN4.3] (A248075) - Antibodies.com](https://cdn.antibodies.com/image/catalog/248/A248076_1.jpg?profile=product_alternative)
![SDS-PAGE - Anti-CDK2 Antibody [AN4.3] - BSA and Azide free (A251258) - Antibodies.com](https://cdn.antibodies.com/image/catalog/251/A251259_1.jpg?profile=product_alternative)
